Showing results (221-230 of 289) with videos related to
Sort By:
Pageof 29
Journal of Cancer Research and Clinical Oncology|May 22, 2010
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expressionYu-Quan Xiong, Hui-Chuan Sun, Xiao-Dong Zhu, et al.Cancer|September 2, 2006
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinomaYong-Bing Qian, Ju-Bo Zhang, Wei-Zhong Wu, et al.Proteomics|October 20, 2006
Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitroJie Feng Cui, Yin Kun Liu, Li Jun Zhang, et al.Plos One|April 5, 2013
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinomaLing-Qun Kong, Xiao-Dong Zhu, Hua-Xiang Xu, et al.Plos One|March 18, 2014
Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma is associated with increased autocrine of IGF1Yang Bu, Qing-An Jia, Zheng-Gang Ren, et al.Plos One|August 14, 2013
Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancerWen-Quan Wang, Liang Liu, Hua-Xiang Xu, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|February 9, 2007
Focal nodular hyperplasia of the liver in 86 patientsYing-Hao Shen, Jia Fan, Zhi-Quan Wu, et al.Journal of Cancer Research and Clinical Oncology|July 10, 2004
Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteinsJie-Feng Cui, Yin-Kun Liu, Bo-Shen Pan, et al.Gastroenterology|February 5, 2013
Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomesAnuradha Budhu, Stephanie Roessler, Xuelian Zhao, et al.International Journal of Cancer|January 8, 2011
Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinomaYi-Ming Zhao, Lu Wang, Zhi Dai, et al.Pageof 29